Thus, by elucidating the interplay between the identified biomarkers (IL1B, PTGS2, and SELL) and immune cells (Tregs and neutrophils), a more comprehensive comprehension of the potential comorbid mechanisms underlying AAA and periodontitis can be attained. This evidence concerns the gene SELL and triple-A syndrome.